logo
  

Vipshop Holdings Q3 Profit Surges - Update

Chinese online discount retailer Vipshop Holdings Ltd (VIPS), Tuesday reported a surge in profit for the third quarter, as revenues more-than-doubled as customers and orders increased. Both earnings and revenues for the quarter came in ahead of analysts' estimates. Nevertheless, shares of the company fell five percent in after-hours trade on the Nasdaq.

Guangzhou, China-based Vipshop's third-quarter profit rose to $27.7 million or $0.05 per American depositary share or ADS, up from $12.0 million or $0.02 per ADS last year.

Adjusted earnings for the quarter rose to $0.08 per ADS from $0.03 per ADS a year ago. Analysts polled by Thomson Reuters estimated earnings of $0.07 per ADS for the quarter. Analysts' estimates typically exclude special items.

Vipshop's revenues for the quarter surged 130 percent to $882.6 million from $383.7 million last year. Analysts had a consensus revenue estimate of $863.12 million for the quarter.

CEO Eric Shen said, "We achieved strong growth in total active customers and total orders, which enabled us to further boost both the total net revenues and the net income attributable to our shareholders. Additionally, we continue to have strong adoption in mobile shopping with approximately 57% of our gross merchandise volume coming from mobile devices in the third quarter."

Number of active customers increased 136.8 percent to 9.5 million, while total orders rose to 117.6 percent to 25.5 million.

Gross margins for the quarter improved to 24.9 percent from 24.2 percent last year.

Looking forward to the fourth quarter, the company expects revenues of $1.20 billion to $1.22 billion. Analysts currently expect $1.21 billion for the quarter.

VIPS closed Tuesday's trading at $23.71, down $0.28 or 1.17%. The stock further slipped $1.16 or 4.89% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT